CN102549162A - 用于改善反刍动物健康和/或性能的菌株和方法 - Google Patents
用于改善反刍动物健康和/或性能的菌株和方法 Download PDFInfo
- Publication number
- CN102549162A CN102549162A CN2009801485134A CN200980148513A CN102549162A CN 102549162 A CN102549162 A CN 102549162A CN 2009801485134 A CN2009801485134 A CN 2009801485134A CN 200980148513 A CN200980148513 A CN 200980148513A CN 102549162 A CN102549162 A CN 102549162A
- Authority
- CN
- China
- Prior art keywords
- strain
- nrrl
- bacterial strain
- bacterial
- animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 60
- 230000036541 health Effects 0.000 title claims abstract description 12
- 241000282849 Ruminantia Species 0.000 title abstract description 3
- 241000194103 Bacillus pumilus Species 0.000 claims abstract description 27
- 241000194031 Enterococcus faecium Species 0.000 claims abstract description 5
- 230000001580 bacterial effect Effects 0.000 claims description 153
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 90
- 241001465754 Metazoa Species 0.000 claims description 78
- 241000283690 Bos taurus Species 0.000 claims description 70
- 210000003608 fece Anatomy 0.000 claims description 66
- 239000010871 livestock manure Substances 0.000 claims description 66
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 52
- 235000014655 lactic acid Nutrition 0.000 claims description 45
- 239000004310 lactic acid Substances 0.000 claims description 45
- 241000635201 Pumilus Species 0.000 claims description 40
- 235000013336 milk Nutrition 0.000 claims description 30
- 239000008267 milk Substances 0.000 claims description 30
- 210000004080 milk Anatomy 0.000 claims description 30
- 239000000463 material Substances 0.000 claims description 28
- 235000013372 meat Nutrition 0.000 claims description 24
- 235000014347 soups Nutrition 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 15
- 244000005700 microbiome Species 0.000 claims description 14
- 230000009467 reduction Effects 0.000 claims description 14
- 238000009825 accumulation Methods 0.000 claims description 13
- GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 claims description 13
- 235000016709 nutrition Nutrition 0.000 claims description 12
- 229930191564 Monensin Natural products 0.000 claims description 11
- GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 claims description 11
- 244000309464 bull Species 0.000 claims description 11
- 229960005358 monensin Drugs 0.000 claims description 11
- 230000003203 everyday effect Effects 0.000 claims description 10
- 230000008901 benefit Effects 0.000 claims description 9
- 235000015278 beef Nutrition 0.000 claims description 8
- 238000011084 recovery Methods 0.000 claims description 8
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 7
- 229930195729 fatty acid Natural products 0.000 claims description 7
- 239000000194 fatty acid Substances 0.000 claims description 7
- 150000004665 fatty acids Chemical class 0.000 claims description 7
- 244000309465 heifer Species 0.000 claims description 6
- 230000004060 metabolic process Effects 0.000 claims description 6
- 230000004044 response Effects 0.000 claims description 4
- 244000309466 calf Species 0.000 claims description 2
- 208000010444 Acidosis Diseases 0.000 abstract 1
- 230000007950 acidosis Effects 0.000 abstract 1
- 208000026545 acidosis disease Diseases 0.000 abstract 1
- 210000004767 rumen Anatomy 0.000 description 51
- 239000000523 sample Substances 0.000 description 44
- 238000012360 testing method Methods 0.000 description 29
- 238000012545 processing Methods 0.000 description 27
- 241000894006 Bacteria Species 0.000 description 24
- 235000013305 food Nutrition 0.000 description 24
- 230000006651 lactation Effects 0.000 description 22
- 239000012530 fluid Substances 0.000 description 20
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 18
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 17
- 239000008103 glucose Substances 0.000 description 17
- 238000009396 hybridization Methods 0.000 description 17
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 16
- 108020004414 DNA Proteins 0.000 description 16
- 235000005911 diet Nutrition 0.000 description 14
- 230000037213 diet Effects 0.000 description 14
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- 230000012010 growth Effects 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 101001064895 Epichloe festucae var. lolii D-lysergyl-peptide-synthetase subunit 1 Proteins 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 230000037396 body weight Effects 0.000 description 8
- 235000021588 free fatty acids Nutrition 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 150000005830 nonesterified fatty acids Chemical class 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 7
- 235000013339 cereals Nutrition 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 235000019260 propionic acid Nutrition 0.000 description 7
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 241000283725 Bos Species 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000002574 poison Substances 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 238000012797 qualification Methods 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 238000007710 freezing Methods 0.000 description 5
- 230000008014 freezing Effects 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000001974 tryptic soy broth Substances 0.000 description 5
- 108010050327 trypticase-soy broth Proteins 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- 241000186429 Propionibacterium Species 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000002555 ionophore Substances 0.000 description 4
- 230000000236 ionophoric effect Effects 0.000 description 4
- 206010025482 malaise Diseases 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000002362 mulch Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000036962 time dependent Effects 0.000 description 4
- NBOODGNJLRRJNA-IAGPQMRQSA-N 2-[(4r,5s,6s,7r,9r,11e,13e,15r,16r)-6-[(2r,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2r,3r,4r,5r,6r)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl Chemical compound OP(O)(O)=O.O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 NBOODGNJLRRJNA-IAGPQMRQSA-N 0.000 description 3
- OBMBUODDCOAJQP-UHFFFAOYSA-N 2-chloro-4-phenylquinoline Chemical compound C=12C=CC=CC2=NC(Cl)=CC=1C1=CC=CC=C1 OBMBUODDCOAJQP-UHFFFAOYSA-N 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 241000194049 Streptococcus equinus Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000021050 feed intake Nutrition 0.000 description 3
- 235000012631 food intake Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000012447 hatching Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 229940116540 protein supplement Drugs 0.000 description 3
- 235000005974 protein supplement Nutrition 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000013179 statistical model Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 229940007392 tylan Drugs 0.000 description 3
- WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 3
- 235000019375 tylosin Nutrition 0.000 description 3
- 229940031989 tylosin phosphate Drugs 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- 108010043797 4-alpha-glucanotransferase Proteins 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 102100040894 Amylo-alpha-1,6-glucosidase Human genes 0.000 description 2
- 235000002198 Annona diversifolia Nutrition 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001112695 Clostridiales Species 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000194033 Enterococcus Species 0.000 description 2
- 206010021703 Indifference Diseases 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- AIJULSRZWUXGPQ-UHFFFAOYSA-N Methylglyoxal Chemical compound CC(=O)C=O AIJULSRZWUXGPQ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 241000186064 Trueperella pyogenes Species 0.000 description 2
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 210000004534 cecum Anatomy 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 238000007621 cluster analysis Methods 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 2
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000008521 reorganization Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 102000008146 Acetate-CoA ligase Human genes 0.000 description 1
- 108010049926 Acetate-CoA ligase Proteins 0.000 description 1
- 244000303258 Annona diversifolia Species 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 241000252983 Caecum Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000003643 Callosities Diseases 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241001595482 Columbicola bacillus Species 0.000 description 1
- 101710089042 Demethyl-4-deoxygadusol synthase Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000605952 Fusobacterium necrophorum Species 0.000 description 1
- 241000605975 Fusobacterium varium Species 0.000 description 1
- 206010018873 Haemoconcentration Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000282838 Lama Species 0.000 description 1
- 206010024652 Liver abscess Diseases 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229920002274 Nalgene Polymers 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000364057 Peoria Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 241001416177 Vicugna pacos Species 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000010828 animal waste Substances 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000012882 sequential analysis Methods 0.000 description 1
- 239000004460 silage Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- NGSFWBMYFKHRBD-UHFFFAOYSA-N sodium;2-hydroxypropanoic acid Chemical compound [Na+].CC(O)C(O)=O NGSFWBMYFKHRBD-UHFFFAOYSA-N 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 238000002627 tracheal intubation Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
Abstract
Description
Claims (29)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410643188.1A CN104762224B (zh) | 2008-12-02 | 2009-12-02 | 用于改善反刍动物健康和/或性能的菌株和方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11925608P | 2008-12-02 | 2008-12-02 | |
US61/119,256 | 2008-12-02 | ||
PCT/US2009/066392 WO2010065625A1 (en) | 2008-12-02 | 2009-12-02 | Strains and methods for improving ruminant health and/or performance |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410643188.1A Division CN104762224B (zh) | 2008-12-02 | 2009-12-02 | 用于改善反刍动物健康和/或性能的菌株和方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102549162A true CN102549162A (zh) | 2012-07-04 |
CN102549162B CN102549162B (zh) | 2015-01-07 |
Family
ID=42233590
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200980148513.4A Expired - Fee Related CN102549162B (zh) | 2008-12-02 | 2009-12-02 | 用于改善反刍动物健康和/或性能的菌株和方法 |
CN201410643188.1A Expired - Fee Related CN104762224B (zh) | 2008-12-02 | 2009-12-02 | 用于改善反刍动物健康和/或性能的菌株和方法 |
CN201580074305.XA Pending CN107205435A (zh) | 2008-12-02 | 2015-11-25 | 用于在反刍动物中进行能量分配的菌株和方法 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410643188.1A Expired - Fee Related CN104762224B (zh) | 2008-12-02 | 2009-12-02 | 用于改善反刍动物健康和/或性能的菌株和方法 |
CN201580074305.XA Pending CN107205435A (zh) | 2008-12-02 | 2015-11-25 | 用于在反刍动物中进行能量分配的菌株和方法 |
Country Status (13)
Country | Link |
---|---|
US (3) | US20100172873A1 (zh) |
EP (1) | EP2370585B1 (zh) |
CN (3) | CN102549162B (zh) |
AU (1) | AU2009322439B2 (zh) |
BR (2) | BRPI0922723B1 (zh) |
CA (2) | CA2908112C (zh) |
DK (1) | DK2370585T3 (zh) |
ES (1) | ES2590482T3 (zh) |
MX (2) | MX337041B (zh) |
PL (1) | PL2370585T3 (zh) |
RU (1) | RU2528859C2 (zh) |
WO (1) | WO2010065625A1 (zh) |
ZA (1) | ZA201104742B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107205435A (zh) * | 2008-12-02 | 2017-09-26 | 杜邦营养生物科学有限公司 | 用于在反刍动物中进行能量分配的菌株和方法 |
CN110392738A (zh) * | 2016-12-28 | 2019-10-29 | 埃斯库斯生物科技股份公司 | 用于对复杂异质群落中的微生物株系进行分析、确定其功能关系及相互作用以及基于此确定诊断和生物状态管理的方法、设备和系统 |
CN116355881A (zh) * | 2023-03-10 | 2023-06-30 | 云南师范大学 | 酸耐受性提高的β-木糖苷酶突变体D395G及其应用 |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107418908B (zh) | 2011-08-24 | 2021-01-08 | 杜邦营养生物科学有限公司 | 产酶芽孢杆菌菌株 |
MX2016014901A (es) | 2014-05-13 | 2017-06-29 | Microbial Discovery Group Llc | Composiciones microbianas para alimentacion directa y sus metodos de uso. |
US20170258111A1 (en) * | 2014-11-26 | 2017-09-14 | Dupont Nutrition Biosciences Aps | Strains and methods for energy partitioning in ruminants |
CA2968734A1 (en) * | 2014-11-26 | 2016-06-02 | Dupont Nutrition Biosciences Aps | Strains and methods for energy partitioning in ruminants |
WO2018126026A1 (en) * | 2016-12-28 | 2018-07-05 | Ascus Biosciences, Inc. | Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon |
CN106689705A (zh) * | 2015-11-16 | 2017-05-24 | 内蒙古伊利实业集团股份有限公司 | 一种改善适口性抗疾病犊牛精补料及其制备方法与应用 |
MX2018010428A (es) | 2016-02-29 | 2018-11-29 | Microbial Discovery Group Llc | Productos microbianos alimentados en directo. |
US10835561B2 (en) | 2016-05-25 | 2020-11-17 | Church & Dwight Co., Inc. | Bacillus compositions and methods of use with ruminants |
US11622569B2 (en) | 2017-07-24 | 2023-04-11 | Church & Dwight Co., Inc. | Bacillus microbial terroir for pathogen control in swine |
MX2021003598A (es) | 2018-09-28 | 2021-05-28 | Microbial Discovery Group Llc | Microorganismos para la inhibicion de patogenos vegetales. |
CN113164529A (zh) * | 2018-10-02 | 2021-07-23 | 微生物发现集团有限责任公司 | 用于动物的微生物 |
WO2020118345A1 (en) * | 2018-12-14 | 2020-06-18 | ProAgni Pty Ltd | Animal feed composition |
WO2021146582A1 (en) | 2020-01-17 | 2021-07-22 | AgBiome, Inc. | Compositions and methods for controlling undesirable microbes and improving animal health |
CN113519718A (zh) * | 2021-07-12 | 2021-10-22 | 广西壮族自治区兽医研究所 | 一种肉鸡益生素饲料添加剂及其制备方法和应用 |
CN114908019B (zh) * | 2022-05-31 | 2023-05-09 | 西南民族大学 | 一种屎肠球菌复合菌剂及其复配方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070071738A1 (en) * | 1998-04-17 | 2007-03-29 | The Board Of Regents For Oklahoma State University | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
US20080118472A1 (en) * | 2004-12-06 | 2008-05-22 | Sage Biosciences Inc. | Method of growing bacteria to deliver bioactive compounds to the intestine of ruminants |
US20080233104A1 (en) * | 1998-08-24 | 2008-09-25 | Sean Farmer | Probiotic, lactic acid-producing bacteria and uses thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63209580A (ja) * | 1987-02-25 | 1988-08-31 | Karupisu Shokuhin Kogyo Kk | バチルス・ズブチリスc−3102 |
US5534271A (en) * | 1994-11-16 | 1996-07-09 | Nutrition Physiology | Process for improving the utilization of feedstuffs by ruminants |
US5529793A (en) * | 1994-11-16 | 1996-06-25 | Nutrition Physiology Corporation | Compositions for improving the utilization of feedstuffs by ruminants |
RU2205216C2 (ru) * | 2000-10-10 | 2003-05-27 | Морозов Василий Юрьевич | Штамм бактерий enterococcus faecium в-2240d - продуцент оптически чистой l(+)-молочной кислоты и промышленный способ получения l(+)-молочной кислоты или ее солей |
RU2353362C2 (ru) * | 2004-05-25 | 2009-04-27 | Пфайзер Продактс Инк. | Новое применение |
CN101253934B (zh) * | 2008-04-07 | 2013-07-24 | 中国农业科学院北京畜牧兽医研究所 | 奶牛饲料用复合微生物添加剂及其制备方法 |
BRPI0922723B1 (pt) * | 2008-12-02 | 2021-10-19 | Lallemand, Inc. | Métodos para fazer uma alimentação direta microbiana |
EP2680860A4 (en) * | 2011-03-03 | 2014-08-20 | Univ Alberta | USE OF BACTERIAL ENDOTOXINES AND LIPOTEIC ACIDS FOR IMPROVED POSTPARTAL HEALTH AND PRODUCTIVITY OF MILK COWS AND THEIR NEWBORN |
CN107418908B (zh) * | 2011-08-24 | 2021-01-08 | 杜邦营养生物科学有限公司 | 产酶芽孢杆菌菌株 |
-
2009
- 2009-12-02 BR BRPI0922723-7A patent/BRPI0922723B1/pt active IP Right Grant
- 2009-12-02 RU RU2011121243/10A patent/RU2528859C2/ru active
- 2009-12-02 MX MX2011005786A patent/MX337041B/es active IP Right Grant
- 2009-12-02 CN CN200980148513.4A patent/CN102549162B/zh not_active Expired - Fee Related
- 2009-12-02 CA CA2908112A patent/CA2908112C/en not_active Expired - Fee Related
- 2009-12-02 US US12/629,497 patent/US20100172873A1/en not_active Abandoned
- 2009-12-02 CA CA2745643A patent/CA2745643C/en active Active
- 2009-12-02 CN CN201410643188.1A patent/CN104762224B/zh not_active Expired - Fee Related
- 2009-12-02 EP EP09831041.0A patent/EP2370585B1/en not_active Not-in-force
- 2009-12-02 AU AU2009322439A patent/AU2009322439B2/en not_active Ceased
- 2009-12-02 PL PL09831041T patent/PL2370585T3/pl unknown
- 2009-12-02 DK DK09831041.0T patent/DK2370585T3/en active
- 2009-12-02 ES ES09831041.0T patent/ES2590482T3/es active Active
- 2009-12-02 WO PCT/US2009/066392 patent/WO2010065625A1/en active Application Filing
-
2011
- 2011-06-27 ZA ZA2011/04742A patent/ZA201104742B/en unknown
-
2014
- 2014-11-26 US US14/554,726 patent/US10172892B2/en not_active Expired - Fee Related
-
2015
- 2015-11-25 CN CN201580074305.XA patent/CN107205435A/zh active Pending
- 2015-11-25 BR BR112017011067A patent/BR112017011067A2/pt not_active Application Discontinuation
- 2015-11-25 MX MX2017006886A patent/MX2017006886A/es unknown
-
2019
- 2019-01-03 US US16/239,187 patent/US20190134112A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070071738A1 (en) * | 1998-04-17 | 2007-03-29 | The Board Of Regents For Oklahoma State University | Propionibacterium P-63 for use in direct fed microbials for animal feeds |
US20080233104A1 (en) * | 1998-08-24 | 2008-09-25 | Sean Farmer | Probiotic, lactic acid-producing bacteria and uses thereof |
US20080118472A1 (en) * | 2004-12-06 | 2008-05-22 | Sage Biosciences Inc. | Method of growing bacteria to deliver bioactive compounds to the intestine of ruminants |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107205435A (zh) * | 2008-12-02 | 2017-09-26 | 杜邦营养生物科学有限公司 | 用于在反刍动物中进行能量分配的菌株和方法 |
CN110392738A (zh) * | 2016-12-28 | 2019-10-29 | 埃斯库斯生物科技股份公司 | 用于对复杂异质群落中的微生物株系进行分析、确定其功能关系及相互作用以及基于此确定诊断和生物状态管理的方法、设备和系统 |
CN116355881A (zh) * | 2023-03-10 | 2023-06-30 | 云南师范大学 | 酸耐受性提高的β-木糖苷酶突变体D395G及其应用 |
CN116355881B (zh) * | 2023-03-10 | 2024-02-23 | 云南师范大学 | 酸耐受性提高的β-木糖苷酶突变体D395G及其应用 |
Also Published As
Publication number | Publication date |
---|---|
EP2370585A4 (en) | 2013-08-14 |
DK2370585T3 (en) | 2016-09-26 |
CN102549162B (zh) | 2015-01-07 |
WO2010065625A1 (en) | 2010-06-10 |
AU2009322439A1 (en) | 2011-06-23 |
US10172892B2 (en) | 2019-01-08 |
ES2590482T3 (es) | 2016-11-22 |
CN104762224A (zh) | 2015-07-08 |
BRPI0922723B1 (pt) | 2021-10-19 |
CN104762224B (zh) | 2019-05-28 |
MX2011005786A (es) | 2011-11-18 |
CA2745643C (en) | 2015-12-01 |
CA2908112C (en) | 2019-07-02 |
CA2745643A1 (en) | 2010-06-10 |
ZA201104742B (en) | 2012-02-29 |
CN107205435A (zh) | 2017-09-26 |
PL2370585T3 (pl) | 2017-08-31 |
EP2370585B1 (en) | 2016-06-22 |
MX337041B (es) | 2016-02-09 |
US20150216916A1 (en) | 2015-08-06 |
RU2011121243A (ru) | 2013-01-10 |
US20190134112A1 (en) | 2019-05-09 |
BR112017011067A2 (pt) | 2018-01-09 |
US20100172873A1 (en) | 2010-07-08 |
RU2528859C2 (ru) | 2014-09-20 |
AU2009322439B2 (en) | 2012-04-26 |
BRPI0922723A2 (pt) | 2020-10-06 |
MX2017006886A (es) | 2018-02-09 |
CA2908112A1 (en) | 2010-06-10 |
EP2370585A1 (en) | 2011-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102549162B (zh) | 用于改善反刍动物健康和/或性能的菌株和方法 | |
Willing et al. | Changes in faecal bacteria associated with concentrate and forage‐only diets fed to horses in training | |
KR100433300B1 (ko) | 사료 생산물 | |
CN102747003B (zh) | 一株益生屎肠球菌的筛选及应用 | |
CN107164269A (zh) | 一种副干酪乳杆菌、制剂及其在猪饲料中的应用 | |
RU2365621C2 (ru) | Штамм megasphaera elsdenii и его применение | |
CN103005159A (zh) | 一种银杏叶生物饲料添加剂的制备方法 | |
Shakira et al. | Effect of indigenously isolated Saccharomyces cerevisiae probiotics on milk production, nutrient digestibility, blood chemistry and fecal microbiota in lactating dairy cows. | |
KR20210043877A (ko) | 복합 균주를 이용한 완전배합 발효사료의 제조방법 | |
CN101392223A (zh) | 一种微生物饲料添加剂菌种的选育方法 | |
CN108522884B (zh) | 一种复合微生态制剂用于预防肉鸡脂肪沉积的用途 | |
CN116478882A (zh) | 能够提高绵羊日增重和饲料转化率的产酸的混合菌制剂的制备方法 | |
CN114908009B (zh) | 一株口粘液乳杆菌pr63及其应用 | |
US20240075080A1 (en) | Use of lactic acid bacteria to inhibit methanogen growth or reduce methane emissions | |
JP2009044971A (ja) | 反芻家畜に対するプロバイオティック効果をサイレージ調製用乳酸菌に付加する新規酵母菌およびその利用 | |
AU2019210497B2 (en) | Strains and methods for improving ruminant health and/or performance | |
AU2012207046A1 (en) | Strains and methods for improving ruminant health and/or performance | |
Galbat et al. | Evaluation of rumen transfaunation after treatment of rumen acidosis in cows | |
CN117467584B (zh) | 一种改善猫肠道健康的复合益生菌菌剂、制备方法及应用 | |
Conklin | Evaluating the impact of Bovamine® on performance, nutrient digestibility, and digestive function in lactating dairy cows | |
CN117736941A (zh) | 一种对犬骨骼有益的地衣芽孢杆菌King58及其应用 | |
CN111961625A (zh) | 一株戊糖片球菌smm914及其筛选方法和应用 | |
Muya | Ruminal Colonization and Potential of Megashaera Elsdenii Ncimb 41125 to Stimulate Rumen Development and its Effects on the Performance Of Pre-Weaned Holstein Calves | |
RODRIGUEZ | OPTIMIZATION OF COST-EFFICIENT AND EFFECTIVE CULTURE MEDIA FOR LACTIC ACID BACTERIA (LAB) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: LALLEMAND USA INC. Effective date: 20141119 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Copenhagen Applicant after: DUPONT NUTRITION BIOSCIENCES APS Applicant after: LALLEMAND, Inc. Address before: Copenhagen Applicant before: DANISCO A/S Applicant before: LALLEMAND, Inc. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: DANISCO TO: DUPONT NUTRITION BIOSCIENCES CO., LTD. |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20141119 Address after: Copenhagen Applicant after: DUPONT NUTRITION BIOSCIENCES APS Address before: Copenhagen Applicant before: DUPONT NUTRITION BIOSCIENCES APS Applicant before: LALLEMAND, Inc. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150107 Termination date: 20211202 |
|
CF01 | Termination of patent right due to non-payment of annual fee |